NCT00277251View on ClinicalTrials.gov

Alendronate Osteoporosis Study

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 31, 2003

Primary Completion Date

June 30, 2006

Study Completion Date

June 30, 2006

Conditions
Glucocorticoid-Associated Osteopenia and Osteoporosis
Interventions
DRUG

Alendronate

All Listed Sponsors
collaborator

Glaser Pediatric Research Network

NETWORK

collaborator

Elizabeth Glaser Pediatric AIDS Foundation

OTHER

lead

Boston Children's Hospital

OTHER

NCT00277251 - Alendronate Osteoporosis Study | Biotech Hunter | Biotech Hunter